메뉴 건너뛰기




Volumn 110, Issue 12, 2014, Pages 2975-2984

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer

Author keywords

Carboplatin; Ovarian cancer; Paclitaxel; Prognosis; Xenograft

Indexed keywords

CARBOPLATIN; FANCONI ANEMIA GROUP D2 PROTEIN; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; PACLITAXEL; PROTEIN P130; PROTEIN P53;

EID: 84902537661     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.258     Document Type: Article
Times cited : (25)

References (39)
  • 3
    • 19744368302 scopus 로고    scopus 로고
    • Cancer of the ovary
    • Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351: 2519-2529
    • (2004) N Engl J Med , vol.351 , pp. 2519-2529
    • Cannistra, S.A.1
  • 7
    • 82355188205 scopus 로고    scopus 로고
    • Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development
    • Dorfman MD, Kerr B, Garcia-Rudaz C, Paredes AH, Dissen GA, Ojeda SR (2011) Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development. Endocrinology 152: 5005-5016
    • (2011) Endocrinology , vol.152 , pp. 5005-5016
    • Dorfman, M.D.1    Kerr, B.2    Garcia-Rudaz, C.3    Paredes, A.H.4    Dissen, G.A.5    Ojeda, S.R.6
  • 8
    • 46249088370 scopus 로고    scopus 로고
    • Lumi: A pipeline for processing Illumina microarray
    • DOI 10.1093/bioinformatics/btn224
    • Du P, Kibbe WA, Lin SM (2008) Lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548. (Pubitemid 351911712
    • (2008) Bioinformatics , vol.24 , Issue.13 , pp. 1547-1548
    • Du, P.1    Kibbe, W.A.2    Lin, S.M.3
  • 11
    • 0031906084 scopus 로고    scopus 로고
    • The role of DNA mismatch repair in drug resistance
    • Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4: 1-6. (Pubitemid 28062870
    • (1998) Clinical Cancer Research , vol.4 , Issue.1 , pp. 1-6
    • Fink, D.1    Aebi, S.2    Howell, S.B.3
  • 14
    • 2442548880 scopus 로고    scopus 로고
    • The human frizzled 6 (hfz6) acts as a negative regulator of the canonical wnt-catenin signaling cascade
    • DOI 10.1074/jbc.M306421200
    • Golan T, Yaniv A, Bafico A, Liu G, Gazit A (2004) The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt . b-catenin signaling cascade. J Biol Chem 279: 14879-14888. (Pubitemid 38618878
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.15 , pp. 14879-14888
    • Golan, T.1    Yaniv, A.2    Bafico, A.3    Liu, G.4    Gazit, A.5
  • 16
    • 77950188189 scopus 로고    scopus 로고
    • Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture
    • Helleman J, Smid M, Jansen MP, van Der Burg ME, Berns EM (2010) Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture. Gynecol Oncol 117: 170-176
    • (2010) Gynecol Oncol , vol.117 , pp. 170-176
    • Helleman, J.1    Smid, M.2    Jansen, M.P.3    Van Der Burg, M.E.4    Berns, E.M.5
  • 17
    • 61449172037 scopus 로고    scopus 로고
    • Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources
    • Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc 4: 44-57
    • (2009) Nat Protoc , vol.4 , pp. 44-57
    • Huang, D.W.1    Sherman, B.T.2    Lempicki, R.A.3
  • 18
    • 0037125582 scopus 로고    scopus 로고
    • Paclitaxel plus carboplatin versus standard chemotherapy with either single-Agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial
    • International Collaborative Ovarian Neoplasm Group
    • International Collaborative Ovarian Neoplasm Group (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-Agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial. Lancet 360: 505-515
    • (2002) Lancet , vol.360 , pp. 505-515
  • 19
  • 21
    • 0037085308 scopus 로고    scopus 로고
    • Liprin b1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-Associated protein S100A4 (Mts1
    • Kriajevska M, Fischer-LarsenM, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N, Lukanidin E (2002) Liprin b1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-Associated protein S100A4 (Mts1). J Biol Chem 277: 5229-5235
    • (2002) J Biol Chem , vol.277 , pp. 5229-5235
    • Kriajevska, M.1    Fischer-Larsen, M.2    Moertz, E.3    Vorm, O.4    Tulchinsky, E.5    Grigorian, M.6    Ambartsumian, N.7    Lukanidin, E.8
  • 22
    • 34247862218 scopus 로고    scopus 로고
    • Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells
    • DOI 10.1038/sj.onc.1210086, PII 1210086
    • Li J, Wood 3rd WH, Becker KG, Weeraratna AT, Morin PJ (2007) Gene expression response to cisplatin treatment in drug-sensitive and drugresistant ovarian cancer cells. Oncogene 26: 2860-2872. (Pubitemid 46701436
    • (2007) Oncogene , vol.26 , Issue.20 , pp. 2860-2872
    • Li, J.1    Wood III, W.H.2    Becker, K.G.3    Weeraratna, A.T.4    Morin, P.J.5
  • 23
    • 61349182713 scopus 로고    scopus 로고
    • Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data
    • Liu J, Campen A, Huang S, Peng SB, Ye X, Palakal M, Dunker AK, Xia Y, Li S (2008) Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data. BMC Med Genomics 1: 39
    • (2008) BMC Med Genomics , vol.1 , pp. 39
    • Liu, J.1    Campen, A.2    Huang, S.3    Peng, S.B.4    Ye, X.5    Palakal, M.6    Dunker, A.K.7    Xia, Y.8    Li, S.9
  • 24
    • 44249118962 scopus 로고    scopus 로고
    • ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis
    • Pabla N, Huang S, Mi QS, Daniel R, Dong Z (2008) ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283: 6572-6583
    • (2008) J Biol Chem , vol.283 , pp. 6572-6583
    • Pabla, N.1    Huang, S.2    Mi, Q.S.3    Daniel, R.4    Dong, Z.5
  • 26
    • 42049107717 scopus 로고    scopus 로고
    • Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells
    • DOI 10.1158/0008-5472.CAN-07-6248
    • Ren A, Yan G, You B, Sun J (2008) Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Cancer Res 68: 2266-2274. (Pubitemid 351521800
    • (2008) Cancer Research , vol.68 , Issue.7 , pp. 2266-2274
    • Ren, A.1    Yan, G.2    You, B.3    Sun, J.4
  • 27
    • 76549107087 scopus 로고    scopus 로고
    • Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumours carrying a mutated RAS gene
    • Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, Versteeg R, Kool M (2010) Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumours carrying a mutated RAS gene. Cancer Res 70: 762-771
    • (2010) Cancer Res , vol.70 , pp. 762-771
    • Schaaf, G.1    Hamdi, M.2    Zwijnenburg, D.3    Lakeman, A.4    Geerts, D.5    Versteeg, R.6    Kool, M.7
  • 28
    • 0034887884 scopus 로고    scopus 로고
    • Cell cycle-mediated drug resistance: An emerging concept in cancer therapy
    • Shah MA, Schwartz GK (2001) Cell cycle-mediated drug resistance: An emerging concept in cancer therapy. Clin Cancer Res 7: 2168-2181. (Pubitemid 32751613
    • (2001) Clinical Cancer Research , vol.7 , Issue.8 , pp. 2168-2181
    • Shah, M.A.1    Schwartz, G.K.2
  • 30
    • 82655176997 scopus 로고    scopus 로고
    • Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    • Sherman-Baust CA, Becker KG, Wood Iii WH, Zhang Y, Morin PJ (2011) Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res 4: 21
    • (2011) J Ovarian Res , vol.4 , pp. 21
    • Sherman-Baust, C.A.1    Becker, K.G.2    Wood III, W.H.3    Zhang, Y.4    Morin, P.J.5
  • 33
    • 33644872577 scopus 로고    scopus 로고
    • Limma: Linear models for microarray data
    • Gentleman RRW, Carey V, Dudoit S, Irizarry R, Huber Huber WRW (eds Springer: New York
    • Smyth GK (2005) Limma: Linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor, Gentleman RRW, Carey V, Dudoit S, Irizarry R, Huber Huber WRW (eds) pp 397-420. Springer: New York
    • (2005) Bioinformatics and Computational Biology Solutions Using R and Bioconductor , pp. 397-420
    • Smyth, G.K.1
  • 39
    • 80053371042 scopus 로고    scopus 로고
    • CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1a
    • Yoon H, Lim JH, Cho CH, Huang LE, Park JW (2011) CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1a. Biochim Biophys Acta 1813: 2008-2016.
    • (2011) Biochim Biophys Acta , vol.1813 , pp. 2008-2016
    • Yoon, H.1    Lim, J.H.2    Cho, C.H.3    Huang, L.E.4    Park, J.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.